🇺🇸 FDA
Pipeline program

Assessment of narrowing of blood vessels after single application of two clascoterone formulations (cream and solution) onto the skin in comparison to three marketed topical corticosteroids

CB-03-01/39

Phase 1 other active

Quick answer

Assessment of narrowing of blood vessels after single application of two clascoterone formulations (cream and solution) onto the skin in comparison to three marketed topical corticosteroids for Test of vasocontriction properties for classification of topical steroid potency is a Phase 1 program (other) at Cassiopea S.p.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Cassiopea S.p.A.
Indication
Test of vasocontriction properties for classification of topical steroid potency
Phase
Phase 1
Modality
other
Status
active

Clinical trials